يعرض 91 - 100 نتائج من 201 نتيجة بحث عن '"Postel-Vinay, S."', وقت الاستعلام: 0.85s تنقيح النتائج
  1. 91
  2. 92
    دورية أكاديمية
  3. 93
    دورية أكاديمية
  4. 94
    دورية أكاديمية

    المساهمون: Garrett, Michelle Dawn, De Bono, Johann, Banerji, Udai, Workman, Paul, Kaye, Stanley Bernard, Attard, Gerhardt, Yap, Timothy, Turner, Lydia

    وصف الملف: Print-Electronic; 97

    العلاقة: Drug discovery today, 2010, 15 (3-4), pp. 88 - 97; https://repository.icr.ac.uk/handle/internal/1964Test

  5. 95
    دورية أكاديمية
  6. 96
    مؤتمر

    المساهمون: Royal Marsden Hospital and the Institute of Cancer Research, London

    العلاقة: http://linkinghub.elsevier.com/retrieve/pii/S0959804916326077Test; Phase I modular study of AZD6738, a novel oral, potent and selective ataxia telangiectasia Rad3-related (ATR) inhibitor in combination (combo) with carboplatin, olaparib or durvalumab in patients (pts) with advanced cancers. 2016, 69(Suppl 1):S2 European Journal of Cancer; http://hdl.handle.net/10541/620226Test; European Journal of Cancer

  7. 97
  8. 98
    دورية
  9. 99
    دورية أكاديمية

    المساهمون: Califano, R., Karamouzis, M. V., Banerjee, S., de Azambuja, E., Guarneri, V., Hutka, M., Jordan, K., Kamposioras, K., Martinelli, E., Corral, J., Postel-Vinay, S., Preusser, M., Porcu, L., Torri, V.

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/24746176; info:eu-repo/semantics/altIdentifier/wos/WOS:000338617100012; volume:85; issue:1; firstpage:74; lastpage:80; numberofpages:7; journal:LUNG CANCER; http://hdl.handle.net/11591/423670Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84901629344; www.elsevier.com/locate/lungcan

  10. 100
    دورية أكاديمية

    المساهمون: Royal Marsden Hospital and The Institute of Cancer Research,Drug Development Unit, London

    العلاقة: Phase I modular study of AZD6738, a novel oral, potent and selective ataxia telangiectasia Rad3-related (ATR) inhibitor in combination (combo) with carboplatin, olaparib or durvalumab in patients (pts) with advanced cancers. 2016, 69:S2 Eur J Cancer; http://hdl.handle.net/10541/620192Test; European Journal of Cancer